Utility of Cytochemical and Flow Cytometry Detection of Alkaline Phosphatase for Differential Diagnosis of CD34 + Acute Leukaemia in Canines
Open Access
- 25 October 2025
- journal article
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 24 (1) , 41-50
Abstract
Alkaline phosphatase (ALP) enzymatic activity has been proposed as a marker for distinguishing canine acute leukaemia (AL) subtypes (i.e., myeloid vs. lymphoid). However, ALP enzymatic activity has not been fully evaluated in CD34+ AL. Determine whether ALP enzymatic activity can differentiate CD34+ AL subtypes in dogs and distinguish CD34+ AL from CD34− haematopoietic tumours in tissue/effusion samples. Peripheral blood from 64 dogs with CD34+ AL, 10 with B cell chronic lymphocytic leukaemia (CLL), and 10 healthy controls were prospectively evaluated for ALP enzymatic activity via cytochemical staining; a subset also underwent ALP detection by flow cytometry (FC). Archived cytology slides from 67 tissue/effusion specimens, including 27 CD34+ AL, 22 T cell lymphomas, and 18 B cell lymphomas, were retrospectively assessed. CD34+ AL cases were categorised as acute myeloid leukaemia (AML), acute lymphoid leukaemia (ALL) or acute unclassifiable leukaemia (AUL) by established FC criteria. ALP positivity was defined as > 3% ALP+ neoplastic cells, which was selected based on receiver operating characteristic (ROC) curve analysis. Cytochemical ALP activity was detected in 61/64 (95.3%) CD34+ AL cases, with no significant differences between AML, ALL, and AUL subtypes ( p > 0.05). All lymphoma and B cell CLL cases were ALP‐negative. FC‐based ALP analysis showed poor concordance with cytochemistry, and the correlation between %CD34 + ALP+ cells and %ALP+ neoplastic cells was weak (Spearman's ρ = 0.25). While ALP enzymatic activity is present in most CD34+ AL cases, it does not reliably differentiate CD34+ AL subtypes via cytochemistry. However, ALP may help distinguish CD34+ AL from B and T cell lymphomas. FC‐based ALP analysis is not a reliable marker for CD34+ AL classification.Keywords
This publication has 26 references indexed in Scilit:
- Clinical outcome and Ki67 evaluation in dogs with nodal small cell B-cell lymphoma diagnosed by flow cytometryJournal of Veterinary Internal Medicine, 2022
- Clinical outcome and prognostic factors in dogs with B-cell chronic lymphocytic leukemia: A retrospective studyJournal of Veterinary Internal Medicine, 2021
- Hematopoietic Tumors2019
- A retrospective review of acute myeloid leukaemia in 35 dogs diagnosed by a combination of morphologic findings, flow cytometric immunophenotyping and cytochemical staining results (2007‐2015)Veterinary and Comparative Oncology, 2017
- Canine acute leukaemia: 50 cases (1989–2014)Veterinary and Comparative Oncology, 2016
- Prognostic factors in canine acute leukaemias: a retrospective studyVeterinary and Comparative Oncology, 2015
- Canine T-Zone Lymphoma: Unique Immunophenotypic Features, Outcome, and Population CharacteristicsJournal of Veterinary Internal Medicine, 2014
- Flow Cytometric Characterization and Clinical Outcome of CD4+ T-Cell Lymphoma in Dogs: 67 CasesJournal of Veterinary Internal Medicine, 2014
- Characterization of pluripotent stem cellsNature Protocols, 2013
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007